-
Posted by
Two Blokes Jun 21 -
Filed in
Stock
-
9 views
Accenture's GenAI pivot is gaining traction, with $5.1B in bookings, but still only 4% of total revenues—progress, but not yet transformative. Q3 earnings and revenue beat expectations, yet bookings contracted 6% year-over-year, signaling persistent macro headwinds and project cancellations. Interestingly, management is increasingly prioritizing share buybacks over acquisitions, reflecting rising confidence in the stock's value and a shift in capital allocation strategy.
